|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2001;72:2050
© 2001 The Society of Thoracic Surgeons
a Ruhr Universität Bochum, Herz- und Diabeteszentrum NRW, Klinik für Thorax- und Kardiovaskularchirurgie, Georgstrasse 11, D-32545 Bad Oeynhausen, Germany
e-mail: rkoerfer@hdz-nrw.de
Terminal heart failure has been one of the leading causes of morbidity and mortality in the 20th century and its treatment will certainly be important in the next decades in industrial countriesdespite increasing understanding of underlying biological processes.
Since the introduction of ventricular assist devices into clinical practice, different heart centers have published successful weaning of patients from the device without heart transplantation, which implies that transient ventricular assist device (VAD) implantation may be an alternative to heart transplantation. Indeed, years of research
Related Article
expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support
Ann. Thorac. Surg. 2001 72: 2044-2050.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |